The Annals of Internal Medicine published the American College of Physicians (ACP) clinical practice guideline addressing noninvasive treatments for acute, subacute, and chronic low back pain. It summarizes evidence-based recommendations to optimize patient care while minimizing unnecessary interventions and harm.
For most patients with acute or subacute low back pain, the ACP recommends nonpharmacologic treatment as the first option. Suggested methods include:
If drug therapy becomes necessary, clinicians should consider nonsteroidal anti-inflammatory drugs (NSAIDs) or skeletal muscle relaxants.
For chronic cases, nonpharmacologic treatments should precede medication use. Evidence supports approaches such as:
If these methods do not yield adequate results, the guideline advises using NSAIDs first and considering tramadol or duloxetine as secondary options.
The guideline cautions against long-term opioid use for chronic low back pain due to risks of dependence and limited evidence of durable benefit.
“Clinicians should avoid costly and potentially harmful treatments and focus on evidence-based noninvasive approaches.”
These recommendations emphasize a patient-centered approach, encouraging the use of safe, effective, and affordable therapies tailored to individual needs and pain duration.
Author summary: ACP advises prioritizing natural, evidence-based therapies—heat, exercise, mindfulness—over drugs or invasive treatments for low back pain management.